CR8748A - Una composicion farmaceutica antimicobacteriana - Google Patents

Una composicion farmaceutica antimicobacteriana

Info

Publication number
CR8748A
CR8748A CR8748A CR8748A CR8748A CR 8748 A CR8748 A CR 8748A CR 8748 A CR8748 A CR 8748A CR 8748 A CR8748 A CR 8748A CR 8748 A CR8748 A CR 8748A
Authority
CR
Costa Rica
Prior art keywords
antimicobacterial
pharmaceutical composition
methyl
composition
pyridylcarboxamide
Prior art date
Application number
CR8748A
Other languages
English (en)
Inventor
Sudershan Kumar Arora
Neelima Sinha
Rakesh Sinha
Ram Shankar Upadhyaya
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of CR8748A publication Critical patent/CR8748A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/131Amines acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen una combinacion antimicobacteriana y una composicion para tratar tuberculosis. Los compuestos usados son N-(3-[[4-(3-trifluorometilfenil)piperazinil]metil]-2-metil-5-fenil-pirrolil)-4-piridilcarboxamida de la formula (I) o su sal no toxica farmaceuticamente aceptable y una cantidad de uno o mas farmacos antituberculosos de primera linea.
CR8748A 2004-05-12 2006-11-10 Una composicion farmaceutica antimicobacteriana CR8748A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/844,992 US7491721B2 (en) 2004-05-12 2004-05-12 Antimycobacterial pharmaceutical composition

Publications (1)

Publication Number Publication Date
CR8748A true CR8748A (es) 2008-06-02

Family

ID=34960626

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8748A CR8748A (es) 2004-05-12 2006-11-10 Una composicion farmaceutica antimicobacteriana

Country Status (45)

Country Link
US (1) US7491721B2 (es)
EP (1) EP1750765B1 (es)
JP (1) JP2007537242A (es)
KR (1) KR100854309B1 (es)
CN (1) CN1956732B (es)
AP (1) AP1994A (es)
AR (1) AR048948A1 (es)
AT (1) ATE373488T1 (es)
AU (1) AU2004319259A1 (es)
BR (1) BRPI0418770A (es)
CA (1) CA2566440C (es)
CR (1) CR8748A (es)
DE (1) DE602004009113T2 (es)
DK (1) DK1750765T3 (es)
DO (1) DOP2005000085A (es)
EA (1) EA009694B1 (es)
EC (1) ECSP066965A (es)
ES (1) ES2294577T3 (es)
GE (1) GEP20094805B (es)
HK (1) HK1098962A1 (es)
HN (1) HN2005000210A (es)
HR (1) HRP20070574T3 (es)
IL (1) IL178858A (es)
IS (1) IS8559A (es)
JO (1) JO2471B1 (es)
MA (1) MA28603B1 (es)
MX (1) MXPA06012984A (es)
MY (1) MY139187A (es)
NI (1) NI200600270A (es)
NO (1) NO20065725L (es)
NZ (1) NZ550892A (es)
PA (1) PA8633001A1 (es)
PE (1) PE20060353A1 (es)
PL (1) PL1750765T3 (es)
PT (1) PT1750765E (es)
RS (1) RS20060624A (es)
SA (1) SA05260130B1 (es)
SI (1) SI1750765T1 (es)
SM (1) SM200500011B (es)
SV (1) SV2006002109A (es)
TN (1) TNSN06349A1 (es)
UA (1) UA82782C2 (es)
UY (1) UY28893A1 (es)
WO (1) WO2005107809A2 (es)
ZA (1) ZA200608843B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006109323A1 (en) * 2005-04-11 2006-10-19 Lupin Limited Preparation of [2-methyl-5-phenyl-3-(piperazin-1-ylmethyl)] pyrrole derivatives
JP5339840B2 (ja) * 2008-10-02 2013-11-13 公益財団法人微生物化学研究会 抗xdr−tb薬、抗mdr−tb薬、及び併用抗結核薬
US9198913B2 (en) * 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
EP2475365A1 (en) * 2009-09-11 2012-07-18 Vertex Pharmaceuticals Incorporated Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyri(dyl)-1-[2-[4-pyridyl)ethyl]propyl]propanamide and uses thereof
HUP1000033A2 (en) * 2010-01-21 2011-07-28 Uratim Kft Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) * 2021-10-20 2022-11-03 순천향대학교 산학협력단 신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227383A (en) * 1991-06-14 1993-07-13 The University Of Mississippi Compounds and compositions useful as antifungal and antimycobacterial agents
RS20050231A (en) * 2002-09-20 2007-06-04 Lupin Limited, Pyrrole derivatives as antimycobacterial compounds

Also Published As

Publication number Publication date
AP1994A (en) 2009-04-09
NZ550892A (en) 2009-12-24
HRP20070574T3 (en) 2008-01-31
DK1750765T3 (da) 2008-01-28
MY139187A (en) 2009-08-28
EP1750765B1 (en) 2007-09-19
CA2566440C (en) 2009-08-04
GEP20094805B (en) 2009-10-26
TNSN06349A1 (en) 2008-02-22
WO2005107809A2 (en) 2005-11-17
PL1750765T3 (pl) 2008-02-29
ECSP066965A (es) 2006-12-20
SM200500011A (it) 2005-11-16
JP2007537242A (ja) 2007-12-20
ZA200608843B (en) 2008-07-30
SI1750765T1 (sl) 2008-04-30
DOP2005000085A (es) 2007-01-15
NO20065725L (no) 2006-12-12
AU2004319259A1 (en) 2005-11-17
JO2471B1 (en) 2009-01-20
MXPA06012984A (es) 2007-04-23
UY28893A1 (es) 2005-12-30
WO2005107809A8 (en) 2006-05-18
PT1750765E (pt) 2007-12-31
EP1750765A2 (en) 2007-02-14
SM200500011B (it) 2005-11-16
DE602004009113D1 (de) 2007-10-31
HN2005000210A (es) 2009-03-17
DE602004009113T2 (de) 2008-06-19
UA82782C2 (uk) 2008-05-12
KR100854309B1 (ko) 2008-08-26
US20050256128A1 (en) 2005-11-17
CA2566440A1 (en) 2005-11-17
PA8633001A1 (es) 2006-12-07
IS8559A (is) 2006-10-26
EA200601952A1 (ru) 2007-02-27
MA28603B1 (fr) 2007-05-02
BRPI0418770A (pt) 2007-10-09
EA009694B1 (ru) 2008-02-28
IL178858A0 (en) 2007-03-08
AP2006003807A0 (en) 2006-12-31
HK1098962A1 (en) 2007-08-03
ATE373488T1 (de) 2007-10-15
US7491721B2 (en) 2009-02-17
PE20060353A1 (es) 2006-07-08
KR20070007920A (ko) 2007-01-16
NI200600270A (es) 2007-12-11
SV2006002109A (es) 2006-04-18
AR048948A1 (es) 2006-06-14
CN1956732A (zh) 2007-05-02
WO2005107809A3 (en) 2006-01-26
CN1956732B (zh) 2010-04-28
RS20060624A (en) 2008-09-29
IL178858A (en) 2010-06-16
SA05260130B1 (ar) 2008-05-04
ES2294577T3 (es) 2008-04-01

Similar Documents

Publication Publication Date Title
CR8748A (es) Una composicion farmaceutica antimicobacteriana
CY1118179T1 (el) Φαρμακευτικη συνθεση
GT200600474A (es) Composiciones farmaceuticas solidas que contienen pregabalina
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
ATE450533T1 (de) Carboxamidderivate
ECSP066950A (es) Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2
ECSP077335A (es) Inhibidores de la interaccion entre mdm2 y p53
ECSP045238A (es) Forma de dosis oral que contiene un inhibidor de pde 4 como un ingrediente activo y polivinilpirrolidona como excipiente
SE0401342D0 (sv) Therapeutic compounds
SG164283A1 (en) New benzimidazole derivatives
BRPI0615158A8 (pt) composto, composição farmacêutica, e, métodos para tratar ou prevenir uma doença ou condição, e para preparar um composto.
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE357928T1 (de) Pharmazeutische zusammensetzung für thrombinpeptidderivaten
UY27979A1 (es) Indoles sustituidos en posición 2,4
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
NO20072303L (no) Kombinasjon av N-(3-metoksy-5-metylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazo 1-2-yl]fenyl)pyridin-3-sulfonamid og et mitotisk middel for behandling av kreft.
SE0302571D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CU20060213A7 (es) Una composición farmacéutica antimicobacteriana
DE602005010725D1 (de) Indolin-2-one-pyridin-derivate, herstellung und therapeutische verwendung dafür
SE0300987D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400025D0 (sv) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0400968D0 (sv) Aryl glycine ether derivatives and their use

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)